S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
Free Trial
NASDAQ:EARS

Auris Medical (EARS) Stock Price, News & Analysis

→ Biden replacement revealed? (From Paradigm Press) (Ad)
Free EARS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$1.42
▼
$1.52
50-Day Range
$2.25
▼
$3.27
52-Week Range
$0.73
▼
$6.60
Volume
24,812 shs
Average Volume
3.10 million shs
Market Capitalization
$17.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsHeadlinesSocial Media
EARS stock logo

About Auris Medical Stock (NASDAQ:EARS)

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

EARS Stock News Headlines

April 16, 2024 | npr.org
The Open Ears Project
April 11, 2024 | msn.com
How to Pop Your Ears on a Plane, According to Medical Experts
April 19, 2024 | DTI (Ad)
Special FREE offer on stock hotsheets
These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?
April 4, 2024 | msn.com
South Euclid pediatrician testing app to diagnose ear infection using a smart phone
April 4, 2024 | msn.com
Can Humans Get Ear Mites From a Pet?
April 1, 2024 | msn.com
Researchers Create An Appropriate Lifelike Replica Of An Adult Human Ear
March 13, 2024 | msn.com
Revolutionary Smartphone App Diagnoses Ear Infections in Children
March 10, 2024 | yahoo.com
Why Pimples Form in the Ear—And How to Get Rid of Them
April 19, 2024 | DTI (Ad)
Special FREE offer on stock hotsheets
These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?
March 7, 2024 | markets.businessinsider.com
Essential Guide for Alleviating Itchy Ears, with Expert Insights from Dr. Emily McMahan
February 28, 2024 | msn.com
Candida Auris Fungus Infection: Symptoms, Spread, Treatment
February 24, 2024 | msn.com
Ear-Tok: Doctors warn of the risks of TikTok ear-cleaning trend
February 18, 2024 | msn.com
Are Your Ears Ringing? 10 Ways to Manage Tinnitus
February 15, 2024 | msn.com
Ear doctor reveals the weirdest things he's ever yanked out
February 14, 2024 | msn.com
New ear tube procedure for children can be done in five minutes
February 11, 2024 | msn.com
'No common symptoms' for deadly fungal disease sweeping US poses 'challenges' for experts
February 8, 2024 | msn.com
Map shows spread of deadly fungal disease across US killing one in three patients
February 8, 2024 | msn.com
The deadly fungal disease C. auris spreading across the US explained - symptoms, treatment and outbreaks
February 6, 2024 | msn.com
What to know about Seattle's potentially deadly fungus outbreak
February 6, 2024 | msn.com
Deadly 'Candida auris' fungal infection spreading rapidly across US with 60% death rate
February 6, 2024 | nytimes.com
What’s the Best Way to Clean Your Ears?
February 6, 2024 | msn.com
Candida Auris Outbreak: Know About This Fatal Fungal Infection Spreading Like Wildfire in the USA
February 5, 2024 | msn.com
Deadly Fungal Infection Spreading to New Parts of U.S., CDC Warns
February 5, 2024 | msn.com
'Nightmare' deadly fungal infection with 60% fatality rate spreading rapidly across US
February 5, 2024 | msn.com
Rare virus detected in US: 4 ‘Candida Auris’ cases reported in Washington – Know all about its symptoms, prevention and history
February 5, 2024 | mirror.co.uk
Deadly fungal infection 'Candida auris' with death rate of 60% spreading rapidly
February 4, 2024 | msn.com
Candida auris: Symptoms to prevention, all about the deadly fungal infection spreading in US
See More Headlines
Receive EARS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Auris Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/11/2017
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EARS
CUSIP
N/A
CIK
1601936
Web
www.aurismedical.com
Phone
(441) 295-5950
Fax
N/A
Employees
132,200
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.83
Quick Ratio
3.83

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.57 per share
Price / Book
0.96

Miscellaneous

Outstanding Shares
11,417,000
Free Float
N/A
Market Cap
$17.13 million
Optionable
Not Optionable
Beta
1.17
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Thomas Meyer
    Chairman & Chief Executive Officer
  • Elmar Schärli
    Chief Financial Officer
  • Samuel A. Wickline
    Chief Scientific Officer
  • Andrea Vondraskova
    Medical Director

Key Competitors

View All Competitors

EARS Stock Analysis - Frequently Asked Questions

How were Auris Medical's earnings last quarter?

Auris Medical Holding Ltd. (NASDAQ:EARS) released its earnings results on Thursday, May, 11th. The biotechnology company reported ($4.40) earnings per share for the quarter, missing the consensus estimate of ($2.80) by $1.60.

When did Auris Medical's stock split?

Auris Medical's stock reverse split before market open on Wednesday, May 1st 2019. The 1-20 reverse split was announced on Tuesday, April 30th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 30th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Auris Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Auris Medical investors own include Helios and Matheson Analytics (HMNY), Anavex Life Sciences (AVXL), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Flexion Therapeutics (FLXN), Novavax (NVAX), Iconix Brand Group (ICON), Onconova Therapeutics (ONTX) and Nabriva Therapeutics (NBRV).

This page (NASDAQ:EARS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes